Cell-type specific delivery of autophagy inducers as a strategy to address localized autophagy impairment in disease
Validation of autophagy induction as a therapeutic strategy: from drug discovery and preclinical evaluation to safety investigation and biomarker research.
Identification of the molecular pathways and microRNAs involved in autophagy deficiency in vascular smooth muscle cells.
IL-23 expression and activation of autophagy in synovium and PBMCs of HLA-B27 positive patients with ankylosing spondylitis. Response to: 'Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of pati
Deficiency in the mitochondrial apoptotic pathway reveals the toxic potential of autophagy under ER stress conditions